1. Home
  2. NTRA vs ERIC Comparison

NTRA vs ERIC Comparison

Compare NTRA & ERIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$244.06

Market Cap

27.0B

Sector

Health Care

ML Signal

HOLD

Logo Ericsson

ERIC

Ericsson

HOLD

Current Price

$9.50

Market Cap

31.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
ERIC
Founded
2003
1876
Country
United States
Sweden
Employees
N/A
N/A
Industry
Medical Specialities
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
27.0B
31.1B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
NTRA
ERIC
Price
$244.06
$9.50
Analyst Decision
Strong Buy
Hold
Analyst Count
16
1
Target Price
$227.69
$9.80
AVG Volume (30 Days)
1.7M
11.3M
Earning Date
11-06-2025
01-23-2026
Dividend Yield
N/A
2.05%
EPS Growth
N/A
N/A
EPS
N/A
0.78
Revenue
$2,116,676,000.00
$25,502,929,121.00
Revenue This Year
$32.77
N/A
Revenue Next Year
$16.51
N/A
P/E Ratio
N/A
$12.21
Revenue Growth
38.17
N/A
52 Week Low
$125.38
$6.64
52 Week High
$245.59
$10.35

Technical Indicators

Market Signals
Indicator
NTRA
ERIC
Relative Strength Index (RSI) 80.03 49.57
Support Level $233.67 $9.51
Resistance Level $240.18 $9.70
Average True Range (ATR) 7.39 0.14
MACD 0.68 -0.03
Stochastic Oscillator 97.49 47.00

Price Performance

Historical Comparison
NTRA
ERIC

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About ERIC Ericsson

Ericsson provides telecom equipment and services that are primarily used to build and operate mobile networks. The firm divides its business into three segments: networks, cloud and software services, and enterprise. Wireless carriers have traditionally been the firm's primary customers, but it is pushing to cater more to enterprises as well, as both try to take advantage of 5G capabilities and utilize "as-a-service" communications platforms. The company also licenses its patents to handset manufacturers.

Share on Social Networks: